[ sulge aken ]

Elulookirjeldus (CV)
1.Eesnimi Allen
2.Perekonnanimi Kaasik
3.Töökoht TÜ Farmakoloogia Instituut
4.Ametikoht vanemteadur
5.Sünniaeg 23.08.1970 (päev.kuu.aasta)
6.Haridus 1995-1998 Tallinna 5. Keskkool
1988-1992 TÜ Bioloogia-geograafia teaduskond -biokeemia
1992-1994 magistrantuur TÜ Patofüsioloogia instituudi juures
1994-1998 doktorantuur TÜ Patofüsioloogia instituudi ja Helsingi Ülikooli Biomeditsiini Instituudi juures
7.Teenistuskäik 1994-1997 TÜ Patofüsioloogia instituudi lektor
1998-1999 TÜ Patofüsioloogia instituudi teadur
1999-2000 postdoktorantuur, INSERM U446, University of Paris-Sud (10 months)
2000- TÜ Farmakoloogia instituudi vanemteadur
2003- TÜ Molekulaarse ja Kliinilise Meditsiini Keskuse juhataja asetäitja
8.Teaduskraad 1998
PhD (Patofüsioloogia)
Tartu Ülikool
9.Teaduskraadi välja
andnud asutus, aasta
1994
MSc (Biomeditsiin)
Tartu Ülikool
10.Tunnustused 2000 Eesti Vabariigi Teaduspreemia meditsiini alal
2001 Eesti Vabariigi Presidendi noore teadlase preemia
11.Teadusorganisatsiooniline
ja –administratiivne
tegevus
ETF, SA Arhimedese, EL FP5 ja INTAS'e retsensent/evaluaator
12.Juhendamisel kaitstud
väitekirjad
13.Teadustöö põhisuunad Bioenergeetika, neuroprotektantide farmakoloogia
14.Jooksvad grandid Eesti Teadusfond
Mitokondri mahu regulatsioon ning selle roll neuronites ja kardiomüotsüütides
2005-2008
15.Teaduspublikatsioonid

Kaasik A, Rikk T, Piirsoo A, Zharkovsky T, Zharkovsky A Upregulation of lysosomal cathepsin L and autophagy during neuronal death induced by reduced serum and potassium. Eur J Neurosci. 2005 Sep;22(5):1023-31

Safiulina D, Veksler V, Zharkovsky A, Kaasik A. Loss of mitochondrial membrane potential is associated with increase in mitochondrial volume. J Cell Physiol. 2005 Aug 18; [Epub ahead of print] Available online

Kaasik A, Joubert F, Ventura-Clapier R, Veksler V. A novel mechanism of regulation of cardiac contractility by mitochondrial functional state. FASEB J. 2004 Aug;18(11):1219-27.

Safiulina D, Kaasik A, Seppet E, Peet N, Zharkovsky A, Seppet E. Method for in situ detection of the mitochondrial function in neurons. J Neurosci Methods. 2004 Aug 15;137(1):87-95.

Ventura-Clapier R, Kaasik A, Veksler V. Structural and functional adaptations of striated muscles to CK deficiency. Mol Cell Biochem. 2004 Jan-Feb;256-257(1-2):29-41

Kaasik A, Safiulina D, Kalda A, Zharkovsky A. Dehydroepiandrosterone with other neurosteroids preserve neuronal mitochondria from calcium overload. J Steroid Biochem Mol Biol. 2003 Oct;87(1):97-103.

Kaasik A, Veksler V, Boehm E, Novotova M, Ventura-Clapier R. From energy store to energy flux: a study in creatine kinase-deficient fast skeletal muscle. FASEB J. 2003 Apr;17(6):708-10.

Zharkovskaja T, Kaasik A, Jaako K, Zharkovsky A. Neurodegeneration and production of the new cells in the dentate gyrus of juvenile rat hippocampus after single administration of ethanol. Brain Research. 2003 Jul 18;978(1-2):115-23.

Kaasik A, Kalda A, Jaako K, Zharkovsky A. Dehydroepiandrosterone sulphate prevents oxygen-glucose deprivation-induced injury in cerebellar granule cell culture. Neurosci. 2001;102(2):427-32.

Kaasik A, Paju K, Minajeva A, Ohisalo JJ. Decreased expression of phospholamban is not associated with lower b-adrenergic activation in rat atria. Mol Cell Biochem. 2001 Jul;223(1-2):109-15.

Kaasik A, Veksler V, Boehm E, Novotova M, Minajeva A, Ventura-Clapier R. Energetic crosstalk between organelles: architectural integration of energy production and utilization. Circ Res. 2001 Jul 20;89(2):153-9.

Kalda A, Kaasik A, Vassiljev V, Pokk P, Zharkovsky A. Neuroprotective action of group I metabotropic glutamate receptor agonists against oxygen-glucose deprivation-induced neuronal death. Brain Res. 2000 Jan 24;853(2):370-3.

De Sousa E, Veksler V, Minajeva A, Kaasik A, Mateo P, Mayoux E, Hoerter J, Bigard X, Serrurier B, Ventura-Clapier R. Subcellular creatine kinase alterations. Implications in heart failure. Circ Res. 1999 Jul 9;85(1):68-76.

Kaasik A, Minajeva A, De Sousa E, Ventura-Clapier R, Veksler V. Nitric oxide inhibits cardiac energy production via inhibition of mitochondrial creatine kinase. FEBS Lett. 1999 Feb 5;444(1):75-7.

Kaasik A, Vassiljev V, Poldoja E, Kalda A, Zharkovsky A. Do nuclear condensation or fragmentation and DNA fragmentation reflect the mode of neuronal death? Neuroreport. 1999 Jun 23;10(9):1937-42

Seppet EK, Kaasik A, Minajeva A, Paju K, Ohisalo JJ, Vetter R, Braun U. Mechanisms of thyroid hormone control over sensitivity and maximal contractile responsiveness to beta-adrenergic agonists in atria. Mol Cell Biochem. 1998 Jul;184(1-2):419-26.

Kaasik A, Minajeva A, Paju K, Eimre M, Seppet EK. Thyroid hormones differentially affect sarcoplasmic reticulum function in rat atria and ventricles. Mol Cell Biochem. 1997 Nov;176(1-2):119-26.

Kaasik A, Paju K, Vetter R, Seppet EK. Thyroid hormones increase the contractility but suppress the effects of beta-adrenergic agonist by decreasing phospholamban expression in rat atria. Cardiovasc Res. 1997 Jul;35(1):106-12.

Minajeva A, Kaasik A, Paju K, Seppet E, Lompre AM, Veksler V, Ventura-Clapier R. Sarcoplasmic reticulum function in determining atrioventricular contractile differences in rat heart. Am J Physiol. 1997 Nov;273(5 Pt 2):H2498-507.

Kaasik A, Ohisalo JJ. Membrane-bound phosphodiesterases in rat myocardium. J Pharm Pharmacol. 1996 Sep;48(9):962-4.

Kaasik A, Elomaa VV, Seppet EK, Ohisalo JJ. Low particulate type IV phosphodiesterase activity in hypothyroid rat atria. J Mol Cell Cardiol. 1994 Dec;26(12):1587-92.

Kaasik A, Seppet EK, Ohisalo JJ. Enhanced negative inotropic effect of an adenosine A1-receptor agonist in rat left atria in hypothyroidism. J Mol Cell Cardiol. 1994 Apr;26(4):509-17.

viimati muudetud: 11.10.2005

Curriculum Vitae (CV)
1.First Name Allen
2.Surname Kaasik
3.Institution Department of Pharmacology, University of Tartu
4.Position senior scientist
5.Date of birth 23.08.1970 (day.month.year)
6.Education 1995-1998 Tallinn Secondary School N 5
1988-1992 Faculty of Biology (Biochemistry)
1992-1994 M.Sci. studies at Dept. Pathophysiology, Univ. Tartu
1994-1998 Ph.D. studies at Dept. Pathophysiology, Univ. Tartu and at Institute of Biomedicine, Univ. Helsinki
7.Research and
professional experience
1994-1997 lecturer, Dept Pathophysiology, University of Tartu
1998-1999 researcher, Dept Pharmacology, University of Tartu
1999-2000 postdoctoral fellow/visiting researcher, INSERM U446 and Dept of Pharmacology Univ Tartu
2000- senior researcher, Dept Pharmacology, Univ Tartu
2003- vice director, Centre of Molecular and Clinical Medicine, University of Tartu
8.Academic degree 1998
PhD (Pathophysiology)University of Tartu
9.Dates and sites of
earning the degrees
1994
MSc (Biomedicine)
University of Tartu
10.Honours/awards 2000 Estonian Republic National Award
2001 Estonian Presidents young investigator award
11.Research-administrative
experience
Expert at EC Research Directorate, INTAS, Archimedes and Estonian Science Foundation
12.Supervised dissertations
13.Current research program Bioenergetics, Pharmacology of the neuroprotectants
14.Current grant funding Estonian Foundation of Science.
Regulation of mitochondrial volume in neurons and cardiomyocytes 2005-2008.
15.List of most important publications

Kaasik A, Rikk T, Piirsoo A, Zharkovsky T, Zharkovsky A Upregulation of lysosomal cathepsin L and autophagy during neuronal death induced by reduced serum and potassium. Eur J Neurosci. 2005 Sep;22(5):1023-31

Safiulina D, Veksler V, Zharkovsky A, Kaasik A. Loss of mitochondrial membrane potential is associated with increase in mitochondrial volume. J Cell Physiol. 2005 Aug 18; [Epub ahead of print] Available online

Kaasik A, Joubert F, Ventura-Clapier R, Veksler V. A novel mechanism of regulation of cardiac contractility by mitochondrial functional state. FASEB J. 2004 Aug;18(11):1219-27.

Safiulina D, Kaasik A, Seppet E, Peet N, Zharkovsky A, Seppet E. Method for in situ detection of the mitochondrial function in neurons. J Neurosci Methods. 2004 Aug 15;137(1):87-95.

Ventura-Clapier R, Kaasik A, Veksler V. Structural and functional adaptations of striated muscles to CK deficiency. Mol Cell Biochem. 2004 Jan-Feb;256-257(1-2):29-41

Kaasik A, Safiulina D, Kalda A, Zharkovsky A. Dehydroepiandrosterone with other neurosteroids preserve neuronal mitochondria from calcium overload. J Steroid Biochem Mol Biol. 2003 Oct;87(1):97-103.

Kaasik A, Veksler V, Boehm E, Novotova M, Ventura-Clapier R. From energy store to energy flux: a study in creatine kinase-deficient fast skeletal muscle. FASEB J. 2003 Apr;17(6):708-10.

Zharkovskaja T, Kaasik A, Jaako K, Zharkovsky A. Neurodegeneration and production of the new cells in the dentate gyrus of juvenile rat hippocampus after single administration of ethanol. Brain Research. 2003 Jul 18;978(1-2):115-23.

Kaasik A, Kalda A, Jaako K, Zharkovsky A. Dehydroepiandrosterone sulphate prevents oxygen-glucose deprivation-induced injury in cerebellar granule cell culture. Neurosci. 2001;102(2):427-32.

Kaasik A, Paju K, Minajeva A, Ohisalo JJ. Decreased expression of phospholamban is not associated with lower b-adrenergic activation in rat atria. Mol Cell Biochem. 2001 Jul;223(1-2):109-15.

Kaasik A, Veksler V, Boehm E, Novotova M, Minajeva A, Ventura-Clapier R. Energetic crosstalk between organelles: architectural integration of energy production and utilization. Circ Res. 2001 Jul 20;89(2):153-9.

Kalda A, Kaasik A, Vassiljev V, Pokk P, Zharkovsky A. Neuroprotective action of group I metabotropic glutamate receptor agonists against oxygen-glucose deprivation-induced neuronal death. Brain Res. 2000 Jan 24;853(2):370-3.

De Sousa E, Veksler V, Minajeva A, Kaasik A, Mateo P, Mayoux E, Hoerter J, Bigard X, Serrurier B, Ventura-Clapier R. Subcellular creatine kinase alterations. Implications in heart failure. Circ Res. 1999 Jul 9;85(1):68-76.

Kaasik A, Minajeva A, De Sousa E, Ventura-Clapier R, Veksler V. Nitric oxide inhibits cardiac energy production via inhibition of mitochondrial creatine kinase. FEBS Lett. 1999 Feb 5;444(1):75-7.

Kaasik A, Vassiljev V, Poldoja E, Kalda A, Zharkovsky A. Do nuclear condensation or fragmentation and DNA fragmentation reflect the mode of neuronal death? Neuroreport. 1999 Jun 23;10(9):1937-42

Seppet EK, Kaasik A, Minajeva A, Paju K, Ohisalo JJ, Vetter R, Braun U. Mechanisms of thyroid hormone control over sensitivity and maximal contractile responsiveness to beta-adrenergic agonists in atria. Mol Cell Biochem. 1998 Jul;184(1-2):419-26.

Kaasik A, Minajeva A, Paju K, Eimre M, Seppet EK. Thyroid hormones differentially affect sarcoplasmic reticulum function in rat atria and ventricles. Mol Cell Biochem. 1997 Nov;176(1-2):119-26.

Kaasik A, Paju K, Vetter R, Seppet EK. Thyroid hormones increase the contractility but suppress the effects of beta-adrenergic agonist by decreasing phospholamban expression in rat atria. Cardiovasc Res. 1997 Jul;35(1):106-12.

Minajeva A, Kaasik A, Paju K, Seppet E, Lompre AM, Veksler V, Ventura-Clapier R. Sarcoplasmic reticulum function in determining atrioventricular contractile differences in rat heart. Am J Physiol. 1997 Nov;273(5 Pt 2):H2498-507.

Kaasik A, Ohisalo JJ. Membrane-bound phosphodiesterases in rat myocardium. J Pharm Pharmacol. 1996 Sep;48(9):962-4.

Kaasik A, Elomaa VV, Seppet EK, Ohisalo JJ. Low particulate type IV phosphodiesterase activity in hypothyroid rat atria. J Mol Cell Cardiol. 1994 Dec;26(12):1587-92.

Kaasik A, Seppet EK, Ohisalo JJ. Enhanced negative inotropic effect of an adenosine A1-receptor agonist in rat left atria in hypothyroidism. J Mol Cell Cardiol. 1994 Apr;26(4):509-17.

last updated: 11.10.2005

[ sulge aken ]